Trials / Recruiting
RecruitingNCT06312813
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
Pilot Studies Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Wright State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imipramine | 4% imipramine |
| DRUG | Amitriptyline | 4% amitriptyline |
| DRUG | Vehicle | 0.1ml propylene glycol |
Timeline
- Start date
- 2024-02-27
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2024-03-15
- Last updated
- 2026-02-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06312813. Inclusion in this directory is not an endorsement.